Nasa Sinnott-Armstrong

Nasa Sinnott-Armstrong

Auto-generated profile, based on publicly available information

Nasa Sinnott-Armstrong

Herbold Computational Biology Program, Fred Hutchinson Cancer Center, Seattle, WA, USA

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
28 August 2017 in Nature Methods
Verified
Journal Article
Closed access
PDF file
MCM Ryan Corces
M Ryan Corces
ATAlexandro E Trevino
Alexandro E Trevino
EHEmily G Hamilton
Emily G Hamilton
PGPeyton G Greenside
Peyton G Greenside
NSNicholas A Sinnott-Armstrong
Nicholas A Sinnott-Armstrong
HCHoward Y Chang
Howard Y Chang

29 March 2019 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
MWMichael Wainberg
Michael Wainberg
NSNasa Sinnott-Armstrong
Nasa Sinnott-Armstrong
NMNicholas Mancuso
Nicholas Mancuso
ABAlvaro N. Barbeira
Alvaro N. Barbeira
DKDavid A. Knowles
David A. Knowles
AKAnshul Kundaje
Anshul Kundaje

18 January 2021 in Nature Genetics
Verified
Journal Article
Closed access
PDF file
NSNasa Sinnott-Armstrong
Nasa Sinnott-Armstrong
Yosuke TanigawaYosuke Tanigawa
Yosuke Tanigawa
DADavid Amar
David Amar
NMNina Mars
Nina Mars
CBChristian Benner
Christian Benner
MRmanuel rivas
manuel rivas

3 December 2018 in Nature Genetics
Verified
Journal Article
Open access
JHJeroen R. Huyghe
Jeroen R. Huyghe
SBStephanie A. Bien
Stephanie A. Bien
THTabitha A. Harrison
Tabitha A. Harrison
HKHyun Min Kang
Hyun Min Kang
SCSai Chen
Sai Chen
UPUlrike Peters
Ulrike Peters
To further dissect the genetic architecture of colorectal cancer (CRC), we performed whole-genome sequencing of 1,439 cases and 720 controls, imputed discovered sequence variants and Haplotype Reference Consortium panel variants into genome-wide association study data, and tested for association in 34,869 cases and 29,051 controls. Findings were followed up in an additional 23,262 cases and 38,296 controls. We discovered a strongly protective 0.3% frequency variant signal at CHD1. In a combined meta-analysis of 125,478 individuals, we identified 40 new independent signals at P < 5 × 10-8, bringing the number of known independent signals for CRC to ~100. New signals implicate lower-frequency variants, Krüppel-like factors, Hedgehog signaling, Hippo-YAP signaling, long noncoding RNAs and somatic drivers, and support a role for immune function. Heritability analyses suggest that CRC risk is highly polygenic, and larger, more comprehensive studies enabling rare variant analysis will improve understanding of biology underlying this risk and influence personalized screening strategies and drug development.

1 August 2022 in Nature Medicine
Verified
Journal Article
Closed access
PDF file
CTCatherine Tcheandjieu
Catherine Tcheandjieu
XZXiang Zhu
Xiang Zhu
AHAustin T. Hilliard
Austin T. Hilliard
SCShoa L. Clarke
Shoa L. Clarke
Valerio NapolioniValerio Napolioni
Valerio Napolioni
MPMillion Veteran Program
Million Veteran Program

21 March 2019 in eLife
Verified
Journal Article
Open access
JBJeremy J Berg
Jeremy J Berg
AHArbel Harpak
Arbel Harpak
NSNasa Sinnott-Armstrong
Nasa Sinnott-Armstrong
AJAnja Moltke Joergensen
Anja Moltke Joergensen
HMHakhamanesh Mostafavi
Hakhamanesh Mostafavi
GCGraham Coop
Graham Coop
Several recent papers have reported strong signals of selection on European polygenic height scores. These analyses used height effect estimates from the GIANT consortium and replication studies. Here, we describe a new analysis based on the the UK Biobank (UKB), a large, independent dataset. We find that the signals of selection using UKB effect estimates are strongly attenuated or absent. We also provide evidence that previous analyses were confounded by population stratification. Therefore, the conclusion of strong polygenic adaptation now lacks support. Moreover, these discrepancies highlight (1) that methods for correcting for population stratification in GWAS may not always be sufficient for polygenic trait analyses, and (2) that claims of differences in polygenic scores between populations should be treated with caution until these issues are better understood.Editorial note: This article has been through an editorial process in which the authors decide how to respond to the issues raised during peer review. The Reviewing Editor's assessment is that all the issues have been addressed (see decision letter).